nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—ACE—forelimb zeugopod—muscle cancer	0.089	0.22	CbGeAlD
Ramipril—BCHE—diaphragm—muscle cancer	0.0725	0.179	CbGeAlD
Ramipril—ACE—hindlimb—muscle cancer	0.0403	0.0997	CbGeAlD
Ramipril—ACE—arm—muscle cancer	0.0385	0.0952	CbGeAlD
Ramipril—ACE—appendage—muscle cancer	0.0346	0.0855	CbGeAlD
Ramipril—SLC15A1—renal system—muscle cancer	0.0121	0.03	CbGeAlD
Ramipril—ACE—embryo—muscle cancer	0.0115	0.0284	CbGeAlD
Ramipril—ACE—smooth muscle tissue—muscle cancer	0.00902	0.0223	CbGeAlD
Ramipril—SLC15A1—vagina—muscle cancer	0.00877	0.0217	CbGeAlD
Ramipril—ACE—renal system—muscle cancer	0.00868	0.0215	CbGeAlD
Ramipril—ACE—cardiac atrium—muscle cancer	0.00778	0.0192	CbGeAlD
Ramipril—SLC15A2—renal system—muscle cancer	0.00757	0.0187	CbGeAlD
Ramipril—BCHE—smooth muscle tissue—muscle cancer	0.00666	0.0165	CbGeAlD
Ramipril—ACE—bone marrow—muscle cancer	0.00657	0.0163	CbGeAlD
Ramipril—ACE—head—muscle cancer	0.00581	0.0144	CbGeAlD
Ramipril—BCHE—cardiac atrium—muscle cancer	0.00574	0.0142	CbGeAlD
Ramipril—ACE—testis—muscle cancer	0.00561	0.0139	CbGeAlD
Ramipril—SLC15A2—vagina—muscle cancer	0.00548	0.0136	CbGeAlD
Ramipril—SLC15A2—head—muscle cancer	0.00507	0.0125	CbGeAlD
Ramipril—SLC15A2—testis—muscle cancer	0.00489	0.0121	CbGeAlD
Ramipril—BCHE—bone marrow—muscle cancer	0.00485	0.012	CbGeAlD
Ramipril—BCHE—vagina—muscle cancer	0.00465	0.0115	CbGeAlD
Ramipril—BCHE—head—muscle cancer	0.00429	0.0106	CbGeAlD
Ramipril—BCHE—testis—muscle cancer	0.00415	0.0103	CbGeAlD
Ramipril—Liver function test abnormal—Methotrexate—muscle cancer	0.00149	0.0025	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00149	0.0025	CcSEcCtD
Ramipril—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00148	0.00248	CcSEcCtD
Ramipril—Insomnia—Vincristine—muscle cancer	0.00148	0.00248	CcSEcCtD
Ramipril—Renal impairment—Doxorubicin—muscle cancer	0.00147	0.00246	CcSEcCtD
Ramipril—Paraesthesia—Vincristine—muscle cancer	0.00147	0.00246	CcSEcCtD
Ramipril—Malaise—Etoposide—muscle cancer	0.00146	0.00245	CcSEcCtD
Ramipril—Breast disorder—Methotrexate—muscle cancer	0.00146	0.00244	CcSEcCtD
Ramipril—Vertigo—Etoposide—muscle cancer	0.00146	0.00244	CcSEcCtD
Ramipril—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00145	0.00244	CcSEcCtD
Ramipril—Leukopenia—Etoposide—muscle cancer	0.00145	0.00243	CcSEcCtD
Ramipril—Purpura—Doxorubicin—muscle cancer	0.00145	0.00243	CcSEcCtD
Ramipril—Abdominal pain—Dactinomycin—muscle cancer	0.00144	0.00242	CcSEcCtD
Ramipril—Body temperature increased—Dactinomycin—muscle cancer	0.00144	0.00242	CcSEcCtD
Ramipril—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00144	0.00242	CcSEcCtD
Ramipril—Cardiac failure—Doxorubicin—muscle cancer	0.00143	0.0024	CcSEcCtD
Ramipril—Hypoglycaemia—Doxorubicin—muscle cancer	0.00143	0.0024	CcSEcCtD
Ramipril—Loss of consciousness—Etoposide—muscle cancer	0.00142	0.00239	CcSEcCtD
Ramipril—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00142	0.00239	CcSEcCtD
Ramipril—Decreased appetite—Vincristine—muscle cancer	0.00142	0.00238	CcSEcCtD
Ramipril—Cough—Etoposide—muscle cancer	0.00141	0.00237	CcSEcCtD
Ramipril—Gastrointestinal disorder—Vincristine—muscle cancer	0.00141	0.00237	CcSEcCtD
Ramipril—Fatigue—Vincristine—muscle cancer	0.00141	0.00236	CcSEcCtD
Ramipril—Convulsion—Etoposide—muscle cancer	0.0014	0.00236	CcSEcCtD
Ramipril—Hyponatraemia—Doxorubicin—muscle cancer	0.0014	0.00235	CcSEcCtD
Ramipril—Constipation—Vincristine—muscle cancer	0.0014	0.00234	CcSEcCtD
Ramipril—Asthma—Methotrexate—muscle cancer	0.00139	0.00234	CcSEcCtD
Ramipril—Chest pain—Etoposide—muscle cancer	0.00138	0.00231	CcSEcCtD
Ramipril—Eosinophilia—Methotrexate—muscle cancer	0.00138	0.00231	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00137	0.0023	CcSEcCtD
Ramipril—Pancreatitis—Methotrexate—muscle cancer	0.00137	0.00229	CcSEcCtD
Ramipril—Discomfort—Etoposide—muscle cancer	0.00136	0.00229	CcSEcCtD
Ramipril—Hypersensitivity—Dactinomycin—muscle cancer	0.00135	0.00226	CcSEcCtD
Ramipril—Abdominal discomfort—Methotrexate—muscle cancer	0.00134	0.00224	CcSEcCtD
Ramipril—Gastrointestinal pain—Vincristine—muscle cancer	0.00134	0.00224	CcSEcCtD
Ramipril—Confusional state—Etoposide—muscle cancer	0.00133	0.00224	CcSEcCtD
Ramipril—Pancytopenia—Methotrexate—muscle cancer	0.00132	0.00222	CcSEcCtD
Ramipril—Anaphylactic shock—Etoposide—muscle cancer	0.00132	0.00222	CcSEcCtD
Ramipril—Asthenia—Dactinomycin—muscle cancer	0.00131	0.0022	CcSEcCtD
Ramipril—Blood creatinine increased—Doxorubicin—muscle cancer	0.00131	0.00219	CcSEcCtD
Ramipril—Neutropenia—Methotrexate—muscle cancer	0.0013	0.00219	CcSEcCtD
Ramipril—Thrombocytopenia—Etoposide—muscle cancer	0.00129	0.00217	CcSEcCtD
Ramipril—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00129	0.00217	CcSEcCtD
Ramipril—Tachycardia—Etoposide—muscle cancer	0.00129	0.00217	CcSEcCtD
Ramipril—Abdominal pain—Vincristine—muscle cancer	0.00129	0.00217	CcSEcCtD
Ramipril—Body temperature increased—Vincristine—muscle cancer	0.00129	0.00217	CcSEcCtD
Ramipril—Liver function test abnormal—Doxorubicin—muscle cancer	0.00129	0.00216	CcSEcCtD
Ramipril—Skin disorder—Etoposide—muscle cancer	0.00128	0.00216	CcSEcCtD
Ramipril—Erectile dysfunction—Methotrexate—muscle cancer	0.00128	0.00215	CcSEcCtD
Ramipril—Hyperhidrosis—Etoposide—muscle cancer	0.00128	0.00215	CcSEcCtD
Ramipril—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00127	0.00214	CcSEcCtD
Ramipril—Abdominal pain upper—Doxorubicin—muscle cancer	0.00127	0.00214	CcSEcCtD
Ramipril—Photosensitivity reaction—Methotrexate—muscle cancer	0.00127	0.00213	CcSEcCtD
Ramipril—Breast disorder—Doxorubicin—muscle cancer	0.00126	0.00212	CcSEcCtD
Ramipril—Anorexia—Etoposide—muscle cancer	0.00126	0.00212	CcSEcCtD
Ramipril—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00126	0.00211	CcSEcCtD
Ramipril—Diarrhoea—Dactinomycin—muscle cancer	0.00125	0.0021	CcSEcCtD
Ramipril—Hypotension—Etoposide—muscle cancer	0.00124	0.00207	CcSEcCtD
Ramipril—Gastritis—Doxorubicin—muscle cancer	0.00124	0.00207	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00123	0.00207	CcSEcCtD
Ramipril—Renal failure—Methotrexate—muscle cancer	0.00122	0.00205	CcSEcCtD
Ramipril—Stomatitis—Methotrexate—muscle cancer	0.00121	0.00203	CcSEcCtD
Ramipril—Conjunctivitis—Methotrexate—muscle cancer	0.00121	0.00203	CcSEcCtD
Ramipril—Asthma—Doxorubicin—muscle cancer	0.00121	0.00202	CcSEcCtD
Ramipril—Dysphagia—Doxorubicin—muscle cancer	0.00121	0.00202	CcSEcCtD
Ramipril—Influenza—Doxorubicin—muscle cancer	0.00121	0.00202	CcSEcCtD
Ramipril—Hypersensitivity—Vincristine—muscle cancer	0.0012	0.00202	CcSEcCtD
Ramipril—Eosinophilia—Doxorubicin—muscle cancer	0.00119	0.002	CcSEcCtD
Ramipril—Sweating—Methotrexate—muscle cancer	0.00119	0.002	CcSEcCtD
Ramipril—Paraesthesia—Etoposide—muscle cancer	0.00119	0.00199	CcSEcCtD
Ramipril—Pancreatitis—Doxorubicin—muscle cancer	0.00118	0.00198	CcSEcCtD
Ramipril—Dyspnoea—Etoposide—muscle cancer	0.00118	0.00198	CcSEcCtD
Ramipril—Somnolence—Etoposide—muscle cancer	0.00118	0.00197	CcSEcCtD
Ramipril—Angina pectoris—Doxorubicin—muscle cancer	0.00118	0.00197	CcSEcCtD
Ramipril—Hepatobiliary disease—Methotrexate—muscle cancer	0.00117	0.00197	CcSEcCtD
Ramipril—Epistaxis—Methotrexate—muscle cancer	0.00117	0.00197	CcSEcCtD
Ramipril—Asthenia—Vincristine—muscle cancer	0.00117	0.00197	CcSEcCtD
Ramipril—Vomiting—Dactinomycin—muscle cancer	0.00116	0.00195	CcSEcCtD
Ramipril—Bronchitis—Doxorubicin—muscle cancer	0.00116	0.00195	CcSEcCtD
Ramipril—Agranulocytosis—Methotrexate—muscle cancer	0.00116	0.00194	CcSEcCtD
Ramipril—Rash—Dactinomycin—muscle cancer	0.00115	0.00193	CcSEcCtD
Ramipril—Decreased appetite—Etoposide—muscle cancer	0.00115	0.00193	CcSEcCtD
Ramipril—Pancytopenia—Doxorubicin—muscle cancer	0.00115	0.00192	CcSEcCtD
Ramipril—Gastrointestinal disorder—Etoposide—muscle cancer	0.00114	0.00192	CcSEcCtD
Ramipril—Fatigue—Etoposide—muscle cancer	0.00114	0.00191	CcSEcCtD
Ramipril—Constipation—Etoposide—muscle cancer	0.00113	0.0019	CcSEcCtD
Ramipril—Neutropenia—Doxorubicin—muscle cancer	0.00113	0.00189	CcSEcCtD
Ramipril—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00112	0.00188	CcSEcCtD
Ramipril—Diarrhoea—Vincristine—muscle cancer	0.00112	0.00187	CcSEcCtD
Ramipril—Hepatitis—Methotrexate—muscle cancer	0.00112	0.00187	CcSEcCtD
Ramipril—Photosensitivity reaction—Doxorubicin—muscle cancer	0.0011	0.00185	CcSEcCtD
Ramipril—Weight increased—Doxorubicin—muscle cancer	0.0011	0.00184	CcSEcCtD
Ramipril—Feeling abnormal—Etoposide—muscle cancer	0.00109	0.00183	CcSEcCtD
Ramipril—Nausea—Dactinomycin—muscle cancer	0.00109	0.00182	CcSEcCtD
Ramipril—Gastrointestinal pain—Etoposide—muscle cancer	0.00108	0.00181	CcSEcCtD
Ramipril—Dizziness—Vincristine—muscle cancer	0.00108	0.00181	CcSEcCtD
Ramipril—Visual impairment—Methotrexate—muscle cancer	0.00107	0.0018	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00107	0.00179	CcSEcCtD
Ramipril—Renal failure—Doxorubicin—muscle cancer	0.00106	0.00177	CcSEcCtD
Ramipril—Erythema multiforme—Methotrexate—muscle cancer	0.00105	0.00177	CcSEcCtD
Ramipril—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00105	0.00177	CcSEcCtD
Ramipril—Urticaria—Etoposide—muscle cancer	0.00105	0.00176	CcSEcCtD
Ramipril—Stomatitis—Doxorubicin—muscle cancer	0.00105	0.00176	CcSEcCtD
Ramipril—Jaundice—Doxorubicin—muscle cancer	0.00105	0.00176	CcSEcCtD
Ramipril—Abdominal pain—Etoposide—muscle cancer	0.00105	0.00175	CcSEcCtD
Ramipril—Body temperature increased—Etoposide—muscle cancer	0.00105	0.00175	CcSEcCtD
Ramipril—Urinary tract infection—Doxorubicin—muscle cancer	0.00105	0.00175	CcSEcCtD
Ramipril—Conjunctivitis—Doxorubicin—muscle cancer	0.00105	0.00175	CcSEcCtD
Ramipril—Tinnitus—Methotrexate—muscle cancer	0.00104	0.00174	CcSEcCtD
Ramipril—Vomiting—Vincristine—muscle cancer	0.00104	0.00174	CcSEcCtD
Ramipril—Sweating—Doxorubicin—muscle cancer	0.00103	0.00173	CcSEcCtD
Ramipril—Rash—Vincristine—muscle cancer	0.00103	0.00173	CcSEcCtD
Ramipril—Dermatitis—Vincristine—muscle cancer	0.00103	0.00173	CcSEcCtD
Ramipril—Headache—Vincristine—muscle cancer	0.00102	0.00172	CcSEcCtD
Ramipril—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00102	0.00171	CcSEcCtD
Ramipril—Epistaxis—Doxorubicin—muscle cancer	0.00101	0.0017	CcSEcCtD
Ramipril—Sinusitis—Doxorubicin—muscle cancer	0.00101	0.00169	CcSEcCtD
Ramipril—Immune system disorder—Methotrexate—muscle cancer	0.00101	0.00169	CcSEcCtD
Ramipril—Mediastinal disorder—Methotrexate—muscle cancer	0.001	0.00169	CcSEcCtD
Ramipril—Agranulocytosis—Doxorubicin—muscle cancer	0.001	0.00168	CcSEcCtD
Ramipril—Alopecia—Methotrexate—muscle cancer	0.000985	0.00165	CcSEcCtD
Ramipril—Mental disorder—Methotrexate—muscle cancer	0.000977	0.00164	CcSEcCtD
Ramipril—Hypersensitivity—Etoposide—muscle cancer	0.000974	0.00163	CcSEcCtD
Ramipril—Malnutrition—Methotrexate—muscle cancer	0.000971	0.00163	CcSEcCtD
Ramipril—Erythema—Methotrexate—muscle cancer	0.000971	0.00163	CcSEcCtD
Ramipril—Nausea—Vincristine—muscle cancer	0.00097	0.00163	CcSEcCtD
Ramipril—Hepatitis—Doxorubicin—muscle cancer	0.000966	0.00162	CcSEcCtD
Ramipril—Oedema peripheral—Doxorubicin—muscle cancer	0.000951	0.0016	CcSEcCtD
Ramipril—Dysgeusia—Methotrexate—muscle cancer	0.000951	0.00159	CcSEcCtD
Ramipril—Asthenia—Etoposide—muscle cancer	0.000949	0.00159	CcSEcCtD
Ramipril—Connective tissue disorder—Doxorubicin—muscle cancer	0.000949	0.00159	CcSEcCtD
Ramipril—Pruritus—Etoposide—muscle cancer	0.000936	0.00157	CcSEcCtD
Ramipril—Visual impairment—Doxorubicin—muscle cancer	0.00093	0.00156	CcSEcCtD
Ramipril—Erythema multiforme—Doxorubicin—muscle cancer	0.000913	0.00153	CcSEcCtD
Ramipril—Diarrhoea—Etoposide—muscle cancer	0.000905	0.00152	CcSEcCtD
Ramipril—Ill-defined disorder—Methotrexate—muscle cancer	0.000901	0.00151	CcSEcCtD
Ramipril—Tinnitus—Doxorubicin—muscle cancer	0.0009	0.00151	CcSEcCtD
Ramipril—Flushing—Doxorubicin—muscle cancer	0.000896	0.0015	CcSEcCtD
Ramipril—Malaise—Methotrexate—muscle cancer	0.000875	0.00147	CcSEcCtD
Ramipril—Dizziness—Etoposide—muscle cancer	0.000875	0.00147	CcSEcCtD
Ramipril—Immune system disorder—Doxorubicin—muscle cancer	0.000872	0.00146	CcSEcCtD
Ramipril—Vertigo—Methotrexate—muscle cancer	0.000872	0.00146	CcSEcCtD
Ramipril—Mediastinal disorder—Doxorubicin—muscle cancer	0.00087	0.00146	CcSEcCtD
Ramipril—Leukopenia—Methotrexate—muscle cancer	0.000869	0.00146	CcSEcCtD
Ramipril—Arrhythmia—Doxorubicin—muscle cancer	0.000863	0.00145	CcSEcCtD
Ramipril—Alopecia—Doxorubicin—muscle cancer	0.000853	0.00143	CcSEcCtD
Ramipril—Cough—Methotrexate—muscle cancer	0.000847	0.00142	CcSEcCtD
Ramipril—Mental disorder—Doxorubicin—muscle cancer	0.000846	0.00142	CcSEcCtD
Ramipril—Convulsion—Methotrexate—muscle cancer	0.000841	0.00141	CcSEcCtD
Ramipril—Vomiting—Etoposide—muscle cancer	0.000841	0.00141	CcSEcCtD
Ramipril—Malnutrition—Doxorubicin—muscle cancer	0.000841	0.00141	CcSEcCtD
Ramipril—Erythema—Doxorubicin—muscle cancer	0.000841	0.00141	CcSEcCtD
Ramipril—Rash—Etoposide—muscle cancer	0.000834	0.0014	CcSEcCtD
Ramipril—Dermatitis—Etoposide—muscle cancer	0.000833	0.0014	CcSEcCtD
Ramipril—Headache—Etoposide—muscle cancer	0.000829	0.00139	CcSEcCtD
Ramipril—Myalgia—Methotrexate—muscle cancer	0.000826	0.00139	CcSEcCtD
Ramipril—Chest pain—Methotrexate—muscle cancer	0.000826	0.00139	CcSEcCtD
Ramipril—Arthralgia—Methotrexate—muscle cancer	0.000826	0.00139	CcSEcCtD
Ramipril—Tension—Doxorubicin—muscle cancer	0.000825	0.00138	CcSEcCtD
Ramipril—Dysgeusia—Doxorubicin—muscle cancer	0.000823	0.00138	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000821	0.00138	CcSEcCtD
Ramipril—Discomfort—Methotrexate—muscle cancer	0.000816	0.00137	CcSEcCtD
Ramipril—Nervousness—Doxorubicin—muscle cancer	0.000816	0.00137	CcSEcCtD
Ramipril—Muscle spasms—Doxorubicin—muscle cancer	0.000808	0.00136	CcSEcCtD
Ramipril—Confusional state—Methotrexate—muscle cancer	0.000799	0.00134	CcSEcCtD
Ramipril—Anaphylactic shock—Methotrexate—muscle cancer	0.000792	0.00133	CcSEcCtD
Ramipril—Nausea—Etoposide—muscle cancer	0.000786	0.00132	CcSEcCtD
Ramipril—Ill-defined disorder—Doxorubicin—muscle cancer	0.00078	0.00131	CcSEcCtD
Ramipril—Nervous system disorder—Methotrexate—muscle cancer	0.000777	0.0013	CcSEcCtD
Ramipril—Thrombocytopenia—Methotrexate—muscle cancer	0.000776	0.0013	CcSEcCtD
Ramipril—Agitation—Doxorubicin—muscle cancer	0.000772	0.0013	CcSEcCtD
Ramipril—Skin disorder—Methotrexate—muscle cancer	0.000769	0.00129	CcSEcCtD
Ramipril—Hyperhidrosis—Methotrexate—muscle cancer	0.000766	0.00128	CcSEcCtD
Ramipril—Malaise—Doxorubicin—muscle cancer	0.000758	0.00127	CcSEcCtD
Ramipril—Vertigo—Doxorubicin—muscle cancer	0.000755	0.00127	CcSEcCtD
Ramipril—Anorexia—Methotrexate—muscle cancer	0.000755	0.00127	CcSEcCtD
Ramipril—Syncope—Doxorubicin—muscle cancer	0.000754	0.00126	CcSEcCtD
Ramipril—Leukopenia—Doxorubicin—muscle cancer	0.000752	0.00126	CcSEcCtD
Ramipril—Palpitations—Doxorubicin—muscle cancer	0.000743	0.00125	CcSEcCtD
Ramipril—Hypotension—Methotrexate—muscle cancer	0.00074	0.00124	CcSEcCtD
Ramipril—Loss of consciousness—Doxorubicin—muscle cancer	0.000739	0.00124	CcSEcCtD
Ramipril—Cough—Doxorubicin—muscle cancer	0.000733	0.00123	CcSEcCtD
Ramipril—Convulsion—Doxorubicin—muscle cancer	0.000728	0.00122	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000722	0.00121	CcSEcCtD
Ramipril—Insomnia—Methotrexate—muscle cancer	0.000717	0.0012	CcSEcCtD
Ramipril—Chest pain—Doxorubicin—muscle cancer	0.000716	0.0012	CcSEcCtD
Ramipril—Myalgia—Doxorubicin—muscle cancer	0.000716	0.0012	CcSEcCtD
Ramipril—Arthralgia—Doxorubicin—muscle cancer	0.000716	0.0012	CcSEcCtD
Ramipril—Anxiety—Doxorubicin—muscle cancer	0.000713	0.0012	CcSEcCtD
Ramipril—Paraesthesia—Methotrexate—muscle cancer	0.000711	0.00119	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000711	0.00119	CcSEcCtD
Ramipril—Discomfort—Doxorubicin—muscle cancer	0.000707	0.00119	CcSEcCtD
Ramipril—Dyspnoea—Methotrexate—muscle cancer	0.000706	0.00119	CcSEcCtD
Ramipril—Somnolence—Methotrexate—muscle cancer	0.000704	0.00118	CcSEcCtD
Ramipril—Dry mouth—Doxorubicin—muscle cancer	0.0007	0.00117	CcSEcCtD
Ramipril—Dyspepsia—Methotrexate—muscle cancer	0.000697	0.00117	CcSEcCtD
Ramipril—Confusional state—Doxorubicin—muscle cancer	0.000692	0.00116	CcSEcCtD
Ramipril—Decreased appetite—Methotrexate—muscle cancer	0.000689	0.00116	CcSEcCtD
Ramipril—Anaphylactic shock—Doxorubicin—muscle cancer	0.000686	0.00115	CcSEcCtD
Ramipril—Oedema—Doxorubicin—muscle cancer	0.000686	0.00115	CcSEcCtD
Ramipril—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000684	0.00115	CcSEcCtD
Ramipril—Fatigue—Methotrexate—muscle cancer	0.000683	0.00115	CcSEcCtD
Ramipril—Shock—Doxorubicin—muscle cancer	0.000675	0.00113	CcSEcCtD
Ramipril—Nervous system disorder—Doxorubicin—muscle cancer	0.000673	0.00113	CcSEcCtD
Ramipril—Thrombocytopenia—Doxorubicin—muscle cancer	0.000672	0.00113	CcSEcCtD
Ramipril—Tachycardia—Doxorubicin—muscle cancer	0.000669	0.00112	CcSEcCtD
Ramipril—Skin disorder—Doxorubicin—muscle cancer	0.000666	0.00112	CcSEcCtD
Ramipril—Hyperhidrosis—Doxorubicin—muscle cancer	0.000663	0.00111	CcSEcCtD
Ramipril—Anorexia—Doxorubicin—muscle cancer	0.000654	0.0011	CcSEcCtD
Ramipril—Feeling abnormal—Methotrexate—muscle cancer	0.000653	0.0011	CcSEcCtD
Ramipril—Gastrointestinal pain—Methotrexate—muscle cancer	0.000648	0.00109	CcSEcCtD
Ramipril—Hypotension—Doxorubicin—muscle cancer	0.000641	0.00108	CcSEcCtD
Ramipril—Urticaria—Methotrexate—muscle cancer	0.000629	0.00106	CcSEcCtD
Ramipril—Abdominal pain—Methotrexate—muscle cancer	0.000626	0.00105	CcSEcCtD
Ramipril—Body temperature increased—Methotrexate—muscle cancer	0.000626	0.00105	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000625	0.00105	CcSEcCtD
Ramipril—Insomnia—Doxorubicin—muscle cancer	0.00062	0.00104	CcSEcCtD
Ramipril—Paraesthesia—Doxorubicin—muscle cancer	0.000616	0.00103	CcSEcCtD
Ramipril—Dyspnoea—Doxorubicin—muscle cancer	0.000612	0.00103	CcSEcCtD
Ramipril—Somnolence—Doxorubicin—muscle cancer	0.00061	0.00102	CcSEcCtD
Ramipril—Dyspepsia—Doxorubicin—muscle cancer	0.000604	0.00101	CcSEcCtD
Ramipril—Decreased appetite—Doxorubicin—muscle cancer	0.000596	0.001	CcSEcCtD
Ramipril—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000592	0.000994	CcSEcCtD
Ramipril—Fatigue—Doxorubicin—muscle cancer	0.000591	0.000992	CcSEcCtD
Ramipril—Constipation—Doxorubicin—muscle cancer	0.000587	0.000984	CcSEcCtD
Ramipril—Hypersensitivity—Methotrexate—muscle cancer	0.000584	0.000979	CcSEcCtD
Ramipril—Asthenia—Methotrexate—muscle cancer	0.000568	0.000954	CcSEcCtD
Ramipril—Feeling abnormal—Doxorubicin—muscle cancer	0.000565	0.000948	CcSEcCtD
Ramipril—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000561	0.000941	CcSEcCtD
Ramipril—Pruritus—Methotrexate—muscle cancer	0.00056	0.00094	CcSEcCtD
Ramipril—Urticaria—Doxorubicin—muscle cancer	0.000545	0.000914	CcSEcCtD
Ramipril—Abdominal pain—Doxorubicin—muscle cancer	0.000542	0.00091	CcSEcCtD
Ramipril—Body temperature increased—Doxorubicin—muscle cancer	0.000542	0.00091	CcSEcCtD
Ramipril—Diarrhoea—Methotrexate—muscle cancer	0.000542	0.000909	CcSEcCtD
Ramipril—Dizziness—Methotrexate—muscle cancer	0.000524	0.000879	CcSEcCtD
Ramipril—Hypersensitivity—Doxorubicin—muscle cancer	0.000505	0.000848	CcSEcCtD
Ramipril—Vomiting—Methotrexate—muscle cancer	0.000504	0.000845	CcSEcCtD
Ramipril—Rash—Methotrexate—muscle cancer	0.000499	0.000838	CcSEcCtD
Ramipril—Dermatitis—Methotrexate—muscle cancer	0.000499	0.000837	CcSEcCtD
Ramipril—Headache—Methotrexate—muscle cancer	0.000496	0.000833	CcSEcCtD
Ramipril—Asthenia—Doxorubicin—muscle cancer	0.000492	0.000826	CcSEcCtD
Ramipril—Pruritus—Doxorubicin—muscle cancer	0.000485	0.000814	CcSEcCtD
Ramipril—Nausea—Methotrexate—muscle cancer	0.000471	0.00079	CcSEcCtD
Ramipril—Diarrhoea—Doxorubicin—muscle cancer	0.000469	0.000788	CcSEcCtD
Ramipril—Dizziness—Doxorubicin—muscle cancer	0.000454	0.000761	CcSEcCtD
Ramipril—Vomiting—Doxorubicin—muscle cancer	0.000436	0.000732	CcSEcCtD
Ramipril—Rash—Doxorubicin—muscle cancer	0.000433	0.000726	CcSEcCtD
Ramipril—Dermatitis—Doxorubicin—muscle cancer	0.000432	0.000725	CcSEcCtD
Ramipril—Headache—Doxorubicin—muscle cancer	0.00043	0.000721	CcSEcCtD
Ramipril—Nausea—Doxorubicin—muscle cancer	0.000407	0.000684	CcSEcCtD
